Hepatitis C Virus Entry Is Impaired by Claudin-1 Downregulation in Diacylglycerol Acyltransferase-1-Deficient Cells

ABSTRACT Diacylglycerol acyltransferase-1 (DGAT1) is involved in the assembly of hepatitis C virus (HCV) by facilitating the trafficking of the HCV core protein to the lipid droplet. Here, we abrogated DGAT1 expression in Huh-7.5 cells by using either the transcription activator-like effector nuclease (TALEN) or lentivirus vector short hairpin RNA (shRNA) and achieved complete long-term silencing of DGAT1. HCV entry was severely impaired in DGAT1-silenced Huh-7.5 cell lines, which showed markedly diminished claudin-1 (CLDN1) expression. In DGAT1-silenced cell lines, the forced expression of CLDN1 restored HCV entry, implying that the downregulation of CLDN1 is a critical factor underlying defective HCV entry. The expression of the gene coding for hepatocyte nuclear factor 4α (HNF4α) and other hepatocyte-specific genes was also reduced in DGAT1-silenced cell lines. After DGAT1 gene rescue, CLDN1 expression was preserved, and HCV entry was restored. Strikingly, after DGAT1 silencing, CLDN1 expression and HCV entry were also restored by low-dose palmitic acid treatment, indicating that the downregulation of CLDN1 was associated with altered fatty acid homeostasis in the absence of DGAT1. Our findings provide novel insight into the role of DGAT1 in the life cycle of HCV. IMPORTANCE In this study, we report the novel effect of complete silencing of DGAT1 on the entry of HCV. DGAT1 was recently reported as a host factor of HCV, involved in the assembly of HCV by facilitating the trafficking of the HCV core protein to lipid droplets. We achieved complete and long-term silencing of DGAT1 by either TALEN or repeated transduction of lentivirus shRNA. We found that HCV entry was severely impaired in DGAT1-silenced cell lines. The impairment of HCV entry was caused by CLDN1 downregulation, and the expression of HNF4α and other hepatocyte-specific genes was also downregulated in DGAT1-silenced cell lines. Our results suggest new roles of DGAT1 in human liver-derived cells: maintaining intracellular lipid homeostasis and affecting HCV entry by modulating CLDN1 expression.

[1]  F. Boudreau,et al.  Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks. , 2014, World journal of gastroenterology.

[2]  Shirly Pinto,et al.  Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors. , 2013, Journal of medicinal chemistry.

[3]  T. Liang,et al.  Current and future therapies for hepatitis C virus infection. , 2013, The New England journal of medicine.

[4]  M. Makishima,et al.  Hepatitis C virus NS4B targets lipid droplets through hydrophobic residues in the amphipathic helices[S] , 2013, Journal of Lipid Research.

[5]  Jin-Soo Kim,et al.  Magnetic Separation and Antibiotics Selection Enable Enrichment of Cells with ZFN/TALEN-Induced Mutations , 2013, PloS one.

[6]  Robert V Farese,et al.  Diacylglycerol Acyltransferase-1 Localizes Hepatitis C Virus NS5A Protein to Lipid Droplets and Enhances NS5A Interaction with the Viral Capsid Core* , 2013, The Journal of Biological Chemistry.

[7]  Duhee Bang,et al.  A library of TAL effector nucleases spanning the human genome , 2013, Nature Biotechnology.

[8]  T. Baumert,et al.  Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges. , 2013, Journal of hepatology.

[9]  Robert V Farese,et al.  DGAT1 mutation is linked to a congenital diarrheal disorder. , 2012, The Journal of clinical investigation.

[10]  T. Wakita,et al.  25‐hydroxyvitamin D3 suppresses hepatitis C virus production , 2012, Hepatology.

[11]  H. Wurie,et al.  Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells , 2012, The FEBS journal.

[12]  Chulhee Choi,et al.  Hepatitis C virus infection enhances TNFα‐induced cell death via suppression of NF‐κB , 2012, Hepatology.

[13]  W. Kang,et al.  Colorimetric Focus-Forming Assay with Automated Focus Counting by Image Analysis for Quantification of Infectious Hepatitis C Virions , 2012, PloS one.

[14]  D. Mu,et al.  Occludin Is a Direct Target of Thyroid Transcription Factor-1 (TTF-1/NKX2–1)* , 2012, The Journal of Biological Chemistry.

[15]  Eugene Bolotin,et al.  Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors , 2012, Nucleic acids research.

[16]  H. Wurie,et al.  Evidence That Diacylglycerol Acyltransferase 1 (DGAT1) Has Dual Membrane Topology in the Endoplasmic Reticulum of HepG2 Cells , 2011, The Journal of Biological Chemistry.

[17]  W. Blaner,et al.  DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle[S] , 2011, Journal of Lipid Research.

[18]  D. Lavanchy,et al.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  Robert V Farese,et al.  Efficient Hepatitis C Virus Particle Formation Requires Diacylglycerol Acyltransferase 1 (DGAT1) , 2010, Nature Medicine.

[20]  C. McClain,et al.  Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[21]  Thuy D. Vo,et al.  Transient cold shock enhances zinc-finger nuclease–mediated gene disruption , 2010, Nature Methods.

[22]  Eugene Bolotin,et al.  Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays , 2010, Hepatology.

[23]  Charles M. Rice,et al.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells , 2009, Nature.

[24]  Robert V Farese,et al.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. , 2008, Journal of lipid research.

[25]  Charles M. Rice,et al.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry , 2007, Nature.

[26]  G. Konopka,et al.  Hepatocyte nuclear factor 4 (cid:1) orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver , 2006 .

[27]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[28]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[29]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Bartosch,et al.  Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.

[31]  T. Wakita,et al.  Processing of hepatitis C virus core protein is regulated by its C‐terminal sequence , 2003, Journal of medical virology.

[32]  Wooin Lee,et al.  The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4 , 2003, Nature Medicine.

[33]  Charles M. Rice,et al.  Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication , 2002, Journal of Virology.

[34]  R. Cortese,et al.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus , 2002, The EMBO journal.

[35]  Jerrold M. Ward,et al.  Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis , 2001, Molecular and Cellular Biology.

[36]  Robert V Farese,et al.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat , 2000, Nature Genetics.

[37]  K. Hofmann.  A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. , 2000, Trends in biochemical sciences.

[38]  R. Kawaguchi,et al.  Real-time detection system for quantification of hepatitis C virus genome. , 1999, Gastroenterology.

[39]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[40]  Robert V Farese,et al.  Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  U. Apte,et al.  Hepatocyte-specific deletion of hepatocyte nuclear factor-4α in adult mice results in increased hepatocyte proliferation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[42]  S. Locarnini,et al.  Antiviral resistance and direct-acting antiviral agents for HCV. , 2012, Antiviral therapy.

[43]  G. Ryffel,et al.  An alternative splice variant of the tissue specific transcription factor HNF4alpha predominates in undifferentiated murine cell types. , 1998, Nucleic acids research.